MedTrace Logo

A New Quantitative Fecal Immunochemical Test in Detecting Colorectal Advanced Adenoma

NCT04473677 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2021-06-18

No results posted yet for this study

Summary

Early detecting and removing of colorectal advanced adenomas can reduce incidence of colorectal cancer. Because of the less bleeding of advanced adenomas, the sensitivity of existing quantitative fecal immunochemical test (qFIT) is unsatisfying. A new technology qFIT, which have a higher sensitivity in extremely low concentration of hemoglobin compared with existing commercially available qFIT, is developed and this study will prove the high diagnostic accuracy in detecting colorectal advanced adenoma.

Conditions

Interventions

DIAGNOSTIC_TEST

The new qFIT and colonoscopy with pathological examination

Detect hemoglobin in stool by the new qFIT before colonoscopy, detect colon lesion using colonoscopy and pathological examination.

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Yanqing Li, PhD · Qilu Hospital, Shandong University

Eligibility

Min Age
50 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-17
Primary Completion
2021-06-11
Completion
2021-06-11

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04473677 on ClinicalTrials.gov